Pinealon

Pinealon (Glu-Asp-Arg, EDR) is a synthetic tripeptide from Vladimir Khavinson's peptide bioregulator program at the Saint Petersburg Institute of Bioregulation and Gerontology. Like other Khavinson bioregulators, Pinealon is proposed to operate through a fundamentally different mechanism than conventional receptor-binding peptides: it is hypothesized to penetrate the cell nucleus and interact directly with specific DNA sequences in the promoter regions of genes relevant to pineal and cortical neuron function, shifting transcriptional patterns toward a more youthful, stress-resilient state.

In vitro studies have demonstrated that Pinealon protects cultured cortical neurons from oxidative stress (H₂O₂ and glutamate toxicity), reduces markers of cellular senescence, and upregulates expression of genes involved in mitochondrial function and antioxidant defense. The peptide's composition — containing both acidic (Glu, Asp) and basic (Arg) residues — gives it a zwitterionic character at physiological pH that may facilitate both membrane penetration and DNA interaction. The arginine residue's guanidinium group is hypothesized to form hydrogen bonds with the DNA minor groove, conferring sequence preference for specific promoter regions.

Beyond the gene-regulatory mechanism, Pinealon has been shown to modulate the hypothalamic-pituitary-adrenal (HPA) axis, reducing stress-induced cortisol elevations and normalizing circadian cortisol rhythms in animal models. This neuroendocrine component — distinct from the direct neuronal effects — suggests Pinealon operates at multiple levels of the stress-cognition axis. The peptide also enhances physical and cognitive performance under conditions of experimental sleep deprivation and CNS stress, making it a research tool of particular interest for studying stress resilience and cognitive preservation under adverse conditions.

Pinealon was developed in the 1990s–2000s at the Saint Petersburg Institute of Bioregulation and Gerontology as part of Khavinson's systematic program to identify short peptide bioregulators for each major organ system. The pineal gland — described by Khavinson as the "biological clock" of the organism — was a priority target given its central role in circadian biology and its progressive calcification and functional decline with age.

Research has focused on Pinealon's neuroprotective and cognitive effects: studies have documented protection of cultured neurons from oxidative damage, improved cognitive performance in aged animal models, and normalization of circadian rhythm disturbances. A series of studies examined Pinealon's effects on operators working under conditions of extreme fatigue and sleep deprivation, with reported improvements in reaction time, error rates, and subjective fatigue measures. As with all Khavinson bioregulators, the evidence base is predominantly from Russian-language publications, and independent Western validation is limited. Pinealon is registered as a dietary supplement in Russia but has no regulatory status in the US or EU.

Store lyophilized Pinealon at -20°C in a light-protected, desiccated container. As a short tripeptide with no disulfide bonds or complex secondary structure, it is relatively stable — the small size and simple structure minimize the degradation pathways available to larger, more structurally complex peptides. Stability exceeds 24 months under optimal conditions.

After reconstitution with bacteriostatic water, Pinealon should be refrigerated at 2–8°C and used within 21 days. The tripeptide's small size and hydrophilic character (all three residues are charged at physiological pH) make it readily water-soluble; the reconstituted solution is clear and colorless. Like Epithalon, Pinealon is typically researched in 10–20 day cycles followed by a 3–6 month washout period rather than as continuous daily administration — the bioregulator paradigm holds that brief, periodic "reminders" to the target tissue are sufficient to reset gene expression patterns. Do not freeze reconstituted solutions.